Answers are grounded in this paper and cite their sources.
Retrospective study reveals blood type B may reduce organ dysfunction and mortality in sepsis patients, indicating a potential protective factor.
Background and Aims Sepsis is a critical and life‐threatening condition marked by a systemic inflammatory response to infection, potentially resulting in multiple organ dysfunction syndrome (MODS). The association between ABO blood type and the occurrence of organ dysfunction in the initial stages of sepsis and ICU 28‐day mortality has rarely been reported. This study aims to elucidate the potential association between ABO blood type and the incidence of organ dysfunction and ICU 28‐day mortality among septic patients. Methods This retrospective observational study was conducted at a single center, including septic patients admitted to our ICU between 2015 and 2021. Patients were categorized based on their ABO blood type. Various clinical characteristics were recorded for each patient. The primary outcome was ICU 28‐day mortality and newly developed or exacerbated organ dysfunction (d/eOD), defined as a net increase in the SOFA score ≥ 2 at least one organ within 7 days of ICU admission. Results A total of 184 sepsis patients were included, of which 166 fulfilled the inclusion criteria. The analysis revealed a significant relationship between ABO blood type and the incidence of d/eOD. Specifically, blood type B patients exhibited the lowest incidence of d/eOD. Blood type B individuals exhibited a significantly lower incidence of d/eOD within 7 days was (26.7% vs. 43.4%, p = 0.03) and reduced the ICU 28‐day mortality (26.7% vs. 52.8%, p < 0.001). Multivariable Cox regression analysis revealed that both blood type B [hazard ratio [HR] 0.42, 95% confidence interval [CI] (0.24–0.74), p = 0.002] and SOFA score [HR 1.14, 95% CI (1.05–1.24), p = 0.003] were significantly correlated with ICU 28‐day mortality. Additionally, blood type B emerged as an independent protective factor against d/eOD [odds ratio [OR] 0.48, 95% CI (0.24–0.96), p = 0.04]. Conclusion Blood type B seems to serve as a protective factor against the incidence of d/eOD during early‐stages sepsis and is associated with lower ICU 28‐day mortality among septic patients.
No takes yet. Share an insight, caveat, or question.
ZHENG et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: